Delivery Order SPE2DB24D2106-SPE2DB24FATYZ
Award Date 3/27/24
Potential Completion Date 3/28/24
Potential Value $3.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,440.48 contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in a 150 ml bottle. The contract has an ultimate completion date of March 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,314.20, is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has a period of performance through May 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue...
- This federal contract award, valued at $2,683.84, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 17, 2025, by the Defense Logistics Agency for Quillivant XR 25 mg/5 ml suspension (120 ml) with a ceiling value of $4,346.15. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and performance will occur in Conshohocken, Pennsylvania. This award was made without a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.48 to DMS Pharmaceutical Group Inc. for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents a single product delivery to support federal pharmaceutical supply needs. The place of performance is listed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $2,412.14 and a completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that specializes in providing a range of pharmaceutical products to federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was awarded a delivery order valued at $1,989.25 by the Defense Logistics Agency (DLA) on July 23, 2025. This firm fixed-price contract calls for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 24, 2025. The award was made without a set-aside designation, allowing the company to...
- This federal contract award issued by the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,537.17 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialized prescription medication. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- This is a $1,903.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialized medication, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,231.66 by the Defense Logistics Agency on August 12, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The contract carries no set-aside designation and is scheduled for completion by August 13, 2025, with performance to take place in Conshohocken, Pennsylvania. This delivery order is issued...